ST Pharm Statistics

Total Valuation

ST Pharm has a market cap or net worth of KRW 2.44 trillion. The enterprise value is 2.40 trillion.

Market Cap	2.44T
Enterprise Value	2.40T

Important Dates

The next estimated earnings date is Thursday, February 5, 2026.

Earnings Date	Feb 5, 2026
Ex-Dividend Date	Dec 27, 2024

Share Statistics

ST Pharm has 20.70 million shares outstanding. The number of shares has increased by 7.23% in one year.

Current Share Class	20.70M
Shares Outstanding	20.70M
Shares Change (YoY)	+7.23%
Shares Change (QoQ)	-2.51%
Owned by Insiders (%)	7.39%
Owned by Institutions (%)	6.57%
Float	12.98M

Valuation Ratios

The trailing PE ratio is 65.73 and the forward PE ratio is 39.97.

PE Ratio	65.73
Forward PE	39.97
PS Ratio	7.67
PB Ratio	4.39
P/TBV Ratio	4.52
P/FCF Ratio	162.82
P/OCF Ratio	26.88
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 30.31, with an EV/FCF ratio of 160.15.

EV / Earnings	65.13
EV / Sales	7.55
EV / EBITDA	30.31
EV / EBIT	46.93
EV / FCF	160.15

Financial Position

The company has a current ratio of 2.04, with a Debt / Equity ratio of 0.14.

Current Ratio	2.04
Quick Ratio	0.96
Debt / Equity	0.14
Debt / EBITDA	1.01
Debt / FCF	5.33
Interest Coverage	6.65

Financial Efficiency

Return on equity (ROE) is 6.89% and return on invested capital (ROIC) is 5.16%.

Return on Equity (ROE)	6.89%
Return on Assets (ROA)	4.44%
Return on Invested Capital (ROIC)	5.16%
Return on Capital Employed (ROCE)	8.86%
Revenue Per Employee	485.98M
Profits Per Employee	56.33M
Employee Count	655
Asset Turnover	0.44
Inventory Turnover	1.16

Taxes

In the past 12 months, ST Pharm has paid 12.92 billion in taxes.

Income Tax	12.92B
Effective Tax Rate	26.42%

Stock Price Statistics

The stock price has increased by +35.48% in the last 52 weeks. The beta is 0.25, so ST Pharm's price volatility has been lower than the market average.

Beta (5Y)	0.25
52-Week Price Change	+35.48%
50-Day Moving Average	99,276.00
200-Day Moving Average	86,618.50
Relative Strength Index (RSI)	70.36
Average Volume (20 Days)	188,648

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ST Pharm had revenue of KRW 318.32 billion and earned 36.89 billion in profits. Earnings per share was 1,795.21.

Revenue	318.32B
Gross Profit	124.70B
Operating Income	51.45B
Pretax Income	48.90B
Net Income	36.89B
EBITDA	79.51B
EBIT	51.45B
Earnings Per Share (EPS)	1,795.21

Full Income Statement

Balance Sheet

The company has 119.38 billion in cash and 80.00 billion in debt, giving a net cash position of 39.38 billion or 1,902.17 per share.

Cash & Cash Equivalents	119.38B
Total Debt	80.00B
Net Cash	39.38B
Net Cash Per Share	1,902.17
Equity (Book Value)	555.98B
Book Value Per Share	26,893.56
Working Capital	181.76B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 90.88 billion and capital expenditures -75.88 billion, giving a free cash flow of 15.00 billion.

Operating Cash Flow	90.88B
Capital Expenditures	-75.88B
Free Cash Flow	15.00B
FCF Per Share	724.73

Full Cash Flow Statement

Margins

Gross margin is 39.17%, with operating and profit margins of 16.16% and 11.59%.

Gross Margin	39.17%
Operating Margin	16.16%
Pretax Margin	15.36%
Profit Margin	11.59%
EBITDA Margin	24.98%
EBIT Margin	16.16%
FCF Margin	4.71%

Dividends & Yields

This stock pays an annual dividend of 500.00, which amounts to a dividend yield of 0.42%.

Dividend Per Share	500.00
Dividend Yield	0.42%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	27.31%
Buyback Yield	-7.23%
Shareholder Yield	-6.80%
Earnings Yield	1.51%
FCF Yield	0.61%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ST Pharm has an Altman Z-Score of 6.47 and a Piotroski F-Score of 6.

Altman Z-Score	6.47
Piotroski F-Score	6